Stockreport

Is It Time To Reconsider Ultragenyx Pharmaceutical (RARE) After A 39.1% One Year Decline? [Yahoo! Finance]

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations
PDF The stock recently closed at US$24.37, with a 7 day return of 8.1%, a 30 day return showing a 32.7% decline, a year to date return of 3.3%, and a 1 year return showing [Read more]